ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 121 filers reported holding ANAPTYSBIO INC in Q4 2019. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $282,000 | +24.8% | 8,085 | -3.0% | 0.00% | 0.0% |
| Q3 2021 | $226,000 | -12.1% | 8,331 | -16.0% | 0.00% | 0.0% |
| Q2 2021 | $257,000 | +25.4% | 9,919 | +4.3% | 0.00% | 0.0% |
| Q1 2021 | $205,000 | -42.1% | 9,507 | -6.1% | 0.00% | -50.0% |
| Q3 2019 | $354,000 | -38.0% | 10,120 | -0.0% | 0.00% | -33.3% |
| Q2 2019 | $571,000 | -31.8% | 10,124 | -11.7% | 0.00% | -40.0% |
| Q1 2019 | $837,000 | +16.2% | 11,462 | +1.5% | 0.01% | 0.0% |
| Q4 2018 | $720,000 | -40.5% | 11,293 | -6.9% | 0.01% | -37.5% |
| Q3 2018 | $1,210,000 | +38.3% | 12,125 | -1.6% | 0.01% | +33.3% |
| Q2 2018 | $875,000 | -36.0% | 12,318 | -6.3% | 0.01% | -33.3% |
| Q1 2018 | $1,368,000 | -11.3% | 13,145 | -14.1% | 0.01% | -18.2% |
| Q4 2017 | $1,542,000 | – | 15,310 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |